Your browser doesn't support javascript.
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
MMWR Morb Mortal Wkly Rep ; 69(33): 1109-1116, 2020 Aug 21.
Article in English | MEDLINE | ID: covidwho-724362
Semantic information from SemMedBD (by NLM)
1. Vaccines ADMINISTERED_TO Adolescent (age group)
Subject
Vaccines
Predicate
ADMINISTERED_TO
Object
Adolescent (age group)
2. Vaccines PART_OF Neisseria meningitidi
Subject
Vaccines
Predicate
PART_OF
Object
Neisseria meningitidi
3. Vaccines ADMINISTERED_TO Persons
Subject
Vaccines
Predicate
ADMINISTERED_TO
Object
Persons
4. Secondary Immunization ADMINISTERED_TO Adolescent (age group)
Subject
Secondary Immunization
Predicate
ADMINISTERED_TO
Object
Adolescent (age group)
5. Vaccines INHIBITS diphtheria toxoid vaccin
Subject
Vaccines
Predicate
INHIBITS
Object
diphtheria toxoid vaccin
6. Vaccines INHIBITS Tetanus Vaccine
Subject
Vaccines
Predicate
INHIBITS
Object
Tetanus Vaccine
7. Vaccines INHIBITS acellular pertussis vaccin
Subject
Vaccines
Predicate
INHIBITS
Object
acellular pertussis vaccin
8. Vaccines INHIBITS Human Papilloma Virus Vaccine
Subject
Vaccines
Predicate
INHIBITS
Object
Human Papilloma Virus Vaccine
9. MenACWY PREVENTS Hydranencephaly with Renal Aplasia-Dysplasia
Subject
MenACWY
Predicate
PREVENTS
Object
Hydranencephaly with Renal Aplasia-Dysplasia
10. Vaccines ADMINISTERED_TO Adolescent (age group)
Subject
Vaccines
Predicate
ADMINISTERED_TO
Object
Adolescent (age group)
11. Vaccines PART_OF Neisseria meningitidis, Serogroup B
Subject
Vaccines
Predicate
PART_OF
Object
Neisseria meningitidis, Serogroup B
12. Vaccines ADMINISTERED_TO Persons
Subject
Vaccines
Predicate
ADMINISTERED_TO
Object
Persons
13. Secondary Immunization ADMINISTERED_TO Adolescent (age group)
Subject
Secondary Immunization
Predicate
ADMINISTERED_TO
Object
Adolescent (age group)
14. Vaccines INHIBITS diphtheria toxoid vaccine, inactivated
Subject
Vaccines
Predicate
INHIBITS
Object
diphtheria toxoid vaccine, inactivated
15. Vaccines INHIBITS Tetanus Vaccine
Subject
Vaccines
Predicate
INHIBITS
Object
Tetanus Vaccine
16. Vaccines INHIBITS acellular pertussis vaccine, inactivated
Subject
Vaccines
Predicate
INHIBITS
Object
acellular pertussis vaccine, inactivated
17. Vaccines INHIBITS Human Papilloma Virus Vaccine
Subject
Vaccines
Predicate
INHIBITS
Object
Human Papilloma Virus Vaccine
18. MenACWY PREVENTS Hydranencephaly with Renal Aplasia-Dysplasia
Subject
MenACWY
Predicate
PREVENTS
Object
Hydranencephaly with Renal Aplasia-Dysplasia
ABSTRACT
Three vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescents aged 11-12 years to protect against 1) pertussis; 2) meningococcal disease caused by types A, C, W, and Y; and 3) human papillomavirus (HPV)-associated cancers (1). At age 16 years, a booster dose of quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended. Persons aged 16-23 years can receive serogroup B meningococcal vaccine (MenB), if determined to be appropriate through shared clinical decision-making. CDC analyzed data from the 2019 National Immunization Survey-Teen (NIS-Teen) to estimate vaccination coverage among adolescents aged 13-17 years in the United States.* Coverage with ≥1 dose of HPV vaccine increased from 68.1% in 2018 to 71.5% in 2019, and the percentage of adolescents who were up to date† with the HPV vaccination series (HPV UTD) increased from 51.1% in 2018 to 54.2% in 2019. Both HPV vaccination coverage measures improved among females and males. An increase in adolescent coverage with ≥1 dose of MenACWY (from 86.6% in 2018 to 88.9% in 2019) also was observed. Among adolescents aged 17 years, 53.7% received the booster dose of MenACWY in 2019, not statistically different from 50.8% in 2018; 21.8% received ≥1 dose of MenB, a 4.6 percentage point increase from 17.2% in 2018. Among adolescents living at or above the poverty level,§ those living outside a metropolitan statistical area (MSA)¶ had lower coverage with ≥1 dose of MenACWY and with ≥1 HPV vaccine dose, and a lower percentage were HPV UTD, compared with those living in MSA principal cities. In early 2020, the coronavirus disease 2019 (COVID-19) pandemic changed the way health care providers operate and provide routine and essential services. An examination of Vaccines for Children (VFC) provider ordering data showed that vaccine orders for HPV vaccine; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap); and MenACWY decreased in mid-March when COVID-19 was declared a national emergency (Supplementary Figure 1, https//stacks.cdc.gov/view/cdc/91795). Ensuring that routine immunization services for adolescents are maintained or reinitiated is essential to continuing progress in protecting persons and communities from vaccine-preventable diseases and outbreaks.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diphtheria-Tetanus-acellular Pertussis Vaccines / Meningococcal Vaccines / Vaccination Coverage / Papillomavirus Vaccines Type of study: Prognostic study Limits: Adolescent / Female / Humans / Male Country/Region as subject: North America Language: English Journal: MMWR Morb Mortal Wkly Rep Year: 2020 Document Type: Article

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diphtheria-Tetanus-acellular Pertussis Vaccines / Meningococcal Vaccines / Vaccination Coverage / Papillomavirus Vaccines Type of study: Prognostic study Limits: Adolescent / Female / Humans / Male Country/Region as subject: North America Language: English Journal: MMWR Morb Mortal Wkly Rep Year: 2020 Document Type: Article